NASDAQ:EARS

Auris Medical (EARS) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$1.40
$1.60
50-Day Range
$2.25
$3.27
52-Week Range
$0.73
$6.60
Volume
3.00 million shs
Average Volume
3.10 million shs
Market Capitalization
$16.44 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
EARS stock logo

About Auris Medical Stock (NASDAQ:EARS)

Auris Medical Holding Ltd. engages in the development of novel products that address unmet medical needs in neurology and central nervous system disorders. It operates through Switzerland and Australia geographical segments. Its product pipeline includes AM-125, AM-201, AM301, Sonsuvi, and Keyzilen. The company was founded by Thomas Meyer in April 2003 and is headquartered in Hamilton, Bermuda.

EARS Stock News Headlines

How to Relieve Ear Pressure
The Open Ears Project
These AI trades triggered this morning (545% return)
If you think a market crash is possible in 2024, I don't know why you're not using this yet.
Can Humans Get Ear Mites From a Pet?
These AI trades triggered this morning (545% return)
If you think a market crash is possible in 2024, I don't know why you're not using this yet.
What’s the Best Way to Clean Your Ears?
See More Headlines
Receive EARS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Auris Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/11/2017
Today
4/25/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:EARS
Fax
N/A
Employees
132,200
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$1.57 per share

Miscellaneous

Free Float
N/A
Market Cap
$16.44 million
Optionable
Not Optionable
Beta
1.17
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Thomas Meyer
    Chairman & Chief Executive Officer
  • Elmar Schärli
    Chief Financial Officer
  • Samuel A. Wickline
    Chief Scientific Officer
  • Andrea Vondraskova
    Medical Director

EARS Stock Analysis - Frequently Asked Questions

How were Auris Medical's earnings last quarter?

Auris Medical Holding Ltd. (NASDAQ:EARS) posted its quarterly earnings results on Thursday, May, 11th. The biotechnology company reported ($4.40) earnings per share for the quarter, missing analysts' consensus estimates of ($2.80) by $1.60.

When did Auris Medical's stock split?

Shares of Auris Medical reverse split on the morning of Wednesday, May 1st 2019. The 1-20 reverse split was announced on Tuesday, April 30th 2019. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, April 30th 2019. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Auris Medical own?
This page (NASDAQ:EARS) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners